Sangamo Therapeutics
SGMO
#9006
Rank
ยฃ95.68 M
Marketcap
ยฃ0.28
Share price
-31.33%
Change (1 day)
-69.79%
Change (1 year)

Market capitalization of Sangamo Therapeutics (SGMO)

Market cap: ยฃ95.68 Million

As of February 2026 Sangamo Therapeutics has a market cap of ยฃ95.68 Million. This makes Sangamo Therapeutics the world's 9006th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sangamo Therapeutics from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ95.68 M-9.9%
2025ยฃ0.10 B-75.05%
2024ยฃ0.42 B462.79%
2023ยฃ75.62 M-82.22%
2022ยฃ0.42 B-47.45%
2021ยฃ0.80 B-50.01%
2020ยฃ1.61 B118.75%
2019ยฃ0.74 B-19.9%
2018ยฃ0.92 B-9.89%
2017ยฃ1.02 B487.52%
2016ยฃ0.17 B-59.73%
2015ยฃ0.43 B-35.76%
2014ยฃ0.67 B28.73%
2013ยฃ0.52 B165.66%
2012ยฃ0.19 B105.78%
2011ยฃ95.87 M-50.88%
2010ยฃ0.19 B18.58%
2009ยฃ0.16 B69.17%
2008ยฃ97.3 M-63.18%
2007ยฃ0.26 B123.77%
2006ยฃ0.11 B65.28%
2005ยฃ71.44 M-9.54%
2004ยฃ78.98 M3.5%
2003ยฃ76.3 M64.3%
2002ยฃ46.44 M-70.55%
2001ยฃ0.15 B-45.5%
2000ยฃ0.28 B

End of Day market cap according to different sources

On Feb 3rd, 2026 the market cap of Sangamo Therapeutics was reported to be:

ยฃ95.68 Million
by Nasdaq info icon info icon
ยฃ95.68 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
ยฃ409.46 B 427,846.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ132.93 B 138,831.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ18.90 B 19,659.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
ยฃ15.95 B 16,570.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ129.61 B 135,371.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ210.95 B 220,380.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ33.88 B 35,316.16%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ8.06 B 8,333.64%๐Ÿ‡บ๐Ÿ‡ธ USA